These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 17662905)

  • 81. [The practice guideline 'vitiligo'].
    Menke HE; van Everdingen JJ
    Ned Tijdschr Geneeskd; 2006 Sep; 150(36):1976-81. PubMed ID: 17002186
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Vitiligo as an aesthetic problem. Noninvasive therapeutic methods in vitiligo].
    Popko M; Kacalak-Rzepka A; Bielecka-Grzela S; Wesołowska J; Klimowicz A; Maleszka R
    Ann Acad Med Stetin; 2011; 57(3):23-7. PubMed ID: 23383544
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy.
    Brazzelli V; Antoninetti M; Palazzini S; Barbagallo T; De Silvestri A; Borroni G
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1369-74. PubMed ID: 17958843
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Keratoacanthoma in vitiligo lesion after UVB narrowband phototherapy.
    Brazzelli V; Barbagallo T; Prestinari F; Vassallo C; Agozzino M; Vailati F; Cespa M; Borroni G
    Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):211-3. PubMed ID: 16869872
    [TBL] [Abstract][Full Text] [Related]  

  • 85. New insights and new therapies in vitiligo.
    Grimes PE
    JAMA; 2005 Feb; 293(6):730-5. PubMed ID: 15701915
    [No Abstract]   [Full Text] [Related]  

  • 86. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study.
    Saraceno R; Nisticò SP; Capriotti E; Chimenti S
    Dermatol Ther; 2009; 22(4):391-4. PubMed ID: 19580584
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Narrowband ultraviolet B phototherapy for inflammatory vitiligo with raised borders associated with Sjögren's syndrome.
    Tanioka M; Takahashi K; Miyachi YI
    Clin Exp Dermatol; 2009 Apr; 34(3):418-20. PubMed ID: 19120387
    [No Abstract]   [Full Text] [Related]  

  • 88. Noncultured keratinocyte/melanocyte cosuspension: effect on reepithelialization and repigmentation--a randomized, placebo-controlled study.
    Back C; Dearman B; Li A; Neild T; Greenwood JE
    J Burn Care Res; 2009; 30(3):408-16. PubMed ID: 19349892
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Response of localized, resistant, tingling vitiligo to pregabalin: A case report.
    Madura C; Harsha S; Kusuma MR; Chandrashekar BS
    Dermatol Ther; 2018 Nov; 31(6):e12702. PubMed ID: 30456812
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Vitiligo Potential Repigmentation Index: a simple clinical score that might predict the ability of vitiligo lesions to repigment under therapy.
    Benzekri L; Ezzedine K; Gauthier Y
    Br J Dermatol; 2013 May; 168(5):1143-6. PubMed ID: 23464539
    [No Abstract]   [Full Text] [Related]  

  • 91. [Clinical findings and therapeutic methods in vitiligo. Patient's own melanocytes produce new pigmentation].
    Olsson MJ; Juhlin L
    Lakartidningen; 1995 Mar; 92(13):1341-4. PubMed ID: 7707778
    [No Abstract]   [Full Text] [Related]  

  • 92. Use of the 308-nm excimer laser for psoriasis and vitiligo.
    Passeron T; Ortonne JP
    Clin Dermatol; 2006; 24(1):33-42. PubMed ID: 16427504
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Validation of phototherapy in vitiligo].
    Koshevenko IuN
    Vestn Dermatol Venerol; 1987; (8):48-51. PubMed ID: 3687193
    [No Abstract]   [Full Text] [Related]  

  • 94. Therapeutic interventions for vitiligo.
    Whitton ME; Ashcroft DM; González U
    J Am Acad Dermatol; 2008 Oct; 59(4):713-7. PubMed ID: 18793940
    [TBL] [Abstract][Full Text] [Related]  

  • 95. What you need to know about .... vitiligo.
    Nurs Times; 2003 Dec 9-15; 99(49):27. PubMed ID: 14705342
    [No Abstract]   [Full Text] [Related]  

  • 96. What's new in hypochromy.
    Passeron T; Ortonne JP
    J Dermatolog Treat; 2006; 17(2):70-3. PubMed ID: 16766328
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Platelet-rich plasma: Potential role in combined therapy for vitiligo.
    Shih S
    Dermatol Ther; 2019 Jan; 32(1):e12773. PubMed ID: 30338878
    [No Abstract]   [Full Text] [Related]  

  • 98. Efficacy of narrowband ultraviolet B versus excimer radiation in repigmenting vitiligo after minigrafting on the distal arms.
    Sheth VM; Currimbhoy SD; Feetham HJ; Graves MS; Chan J; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2012 Aug; 67(2):318-20. PubMed ID: 22794808
    [No Abstract]   [Full Text] [Related]  

  • 99. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
    Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
    Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Phototherapy in childhood.
    Ersoy-Evans S; Altaykan A; Sahin S; Kölemen F
    Pediatr Dermatol; 2008; 25(6):599-605. PubMed ID: 19067863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.